The use of DNA microarrays to investigate the pharmacogenomics of drug response in living systems

Current Topics in Medicinal Chemistry

Volumn 4, Issue 13, 2004, Pages 1329-1345

  Villeneuve, David J ^a   Parissenti, Amadeo M ^a,b,c  

^a Northeastern Ontario Regional Cancer Centre   (Canada)

^b LAURENTIAN UNIVERSITY   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Chemotherapy; DNA microarray; Drug resistance; Drug response; MIAME standards; Pharmacogenomics; Review

Indexed keywords

CARBOPLATIN; CISPLATIN; COLECALCIFEROL; COMPLEMENTARY DNA; COMPLEMENTARY RNA; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; MANGANESE SUPEROXIDE DISMUTASE; METHOTREXATE; MITOMYCIN C; MITOXANTRONE; NIMUSTINE; NITROSOUREA; PACLITAXEL; RALTITREXED; RETINOID; SELENIUM; TAMOXIFEN; VINBLASTINE; VINCRISTINE;

CALCULATION; CLUSTER ANALYSIS; CORRELATION ANALYSIS; DNA MICROARRAY; DRUG EXPOSURE; DRUG MECHANISM; DRUG RESPONSE; DRUG SENSITIVITY; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; IN VIVO STUDY; LEARNING; NONHUMAN; PHARMACOGENOMICS; PRACTICE GUIDELINE; REPRODUCIBILITY; REVIEW; STATISTICAL ANALYSIS;

EID: 4544230338     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568026043387610     Document Type: Review

References (50)

1. Wildsmith, S. E.; Elcock, F. J. Microarrays under the microscope. Mol. Pathol. 2001, 54, 8-16.
2. Deyholos, M. K.; Galbraith, D. W. High-density microarrays for gene expression analysis. Cytometry 2001, 43, 229-238.
3. Schena, M.; Shalon, D.; Davis, R. W.; Brown, P. O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270, 467-470.
4. McGall, G.; Labadie, J.; Brock, P.; Wallraff, G.; Nguyen, T.; Hinsberg, W. Light-directed synthesis of high-density oligonucleotide arrays using semiconductor photoresists. Proc. Natl. Acad. Sci. USA 1996, 93, 13555-13560.
5. Lipshutz, R. J.; Fodor, S. P.; Gingeras, T. R.; Lockhart, D. J. High density synthetic oligonucleotide arrays. Nat. Genet. 1999, 21, 20-24.
6. Tseng, G. C.; Oh, M. K.; Rohlin, L.; Liao, J. C.; Wong, W. H. Issues in cDNA microarray analysis: quality filtering, channel normalization, models of variations and assessment of gene effects. Nucleic Acids Res. 2001, 29, 2549-2557.
7. Ogretmen, B.; McCauley, M. D.; Safa, A. R. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance. Biochemistry 1998, 37, 11679-11691,
8. Hess, K. R.; Zhang, W.; Baggerly, K. A.; Stivers, D. N.; Coombes, K. R. Microarrays: handling the deluge of data and extracting reliable information. Trends Biotechnol. 2001, 19, 463-468.
9. Hegde, P.; Qi, R.; Abernathy, K.; Gay, C.; Dharap, S.; Gaspard, R.; Hughes, J. E.; Snesrud, E.; Lee, N.; Quackenbush, J. A concise guide to cDNA microarray analysis. Biotechniques 2000, 29, 548-4, 556.
10. Brazma, A.; Vilo, J. Gene expression data analysis. FEBS Lett. 2000, 480, 17-24.
11. Svaren, J.; Ehrig, T.; Abdulkadir, S. A.; Ehrengruber, M. U.; Watson, M. A.; Milbrandt, J. EGR1 target genes in prostate carcinoma cells identified by microarray analysis. J. Biol. Chem. 2000, 275, 38524-38531.
12. Lee, M. L.; Kuo, F. C.; Whitmore, G. A.; Sklar, J. Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. Proc. Natl. Acad. Sci. USA 2000, 97, 9834-9839.
13. Kerr, M. K.; Martin, M.; Churchill, G. A. Analysis of variance for gene expression microarray data. J. Comput. Biol. 2000, 7, 819-837.
14. Newton, M. A.; Kendziorski, C. M.; Richmond, C. S.; Blattner, F. R.; Tsui, K. W. On differential variability of expression ratios: improving statistical inference about gene expression changes from microarray data. J. Comput. Biol. 2001, 8, 37-52.
15. Kim, S.; Dougherty, E. R.; Chen, Y.; Sivakumar, K.; Meltzer, P., Trent, J. M.; Bittner, M. Multivariate measurement of gene expression relationships. Genomics 2000, 67, 201-209.
16. Kim, S.; Dougherty, E. R.; Bittner, M. L.; Chen, Y.; Sivakumar, K.; Meltzer, P.; Trent, J. M. General nonlinear framework for the analysis of gene interaction via multivariate expression arrays. J. Biomed. Opt. 2000, 5, 411-424.
17. Raychaudhuri, S.; Sutphin, P. D.; Chang, J. T.; Altman, R. B. Basic microarray analysis: grouping and feature reduction. Trends Biotechnol. 2001, 19, 189-193.
18. Eisen, M. B.; Spellman, P. T.; Brown, P. O.; Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 1998, 95, 14863-14868.
19. Moriyama, M.; Hoshida, Y.; Otsuka, M.; Nishimura, S.; Kato, N.; Goto, T.; Taniguchi, H.; Shiratori, Y.; Seki, N.; Omata, M. Relevance network between chemosensitivity and transcriptome in human hepatoma cells. Mol. Cancer Ther. 2003, 2, 199-205.
20. Tusher, V. G.; Tibshirani, R.; Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 2001, 98, 5116-5121.
21. Brazma, A.; Hingamp, P.; Quackenbush, J.; Sherlock, G.; Spellman, P.; Stoeckert, C.; Aach, J.; Ansorge, W.; Ball, C. A.; Causton, H. C.; Gaasterland, T.; Glenisson, P.; Holstege, F. C.; Kim, I. F.; Markowitz, V.; Matese, J. C.; Parkinson, H.; Robinson, A.; Sarkans, U.; Schulze-Kremer, S.; Stewart, J.; Taylor, R.; Vilo, J.; Vingron, M. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat. Genet. 2001, 29, 365-371.
22. Kudoh, K.; Ramanna, M.; Ravatn, R.; Elkahloun, A. G.; Bittner, M. L.; Meltzer, P. S.; Trent, J. M.; Dalton, W. S.; Chin, K. V. Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res. 2000, 60, 4161-4166.
23. Yuan, R.; Fan, S.; Achary, M.; Stewart, D. M.; Goldberg, I. D.; Rosen, E. M. Altered gene expression pattern in cultured human breast cancer cells treated with hepatocyte growth factor/scatter factor in the setting of DNA damage. Cancer Res. 2001, 61, 8022-8031.
24. Watts, G. S.; Futscher, B. W.; Isett, R.; Gleason-Guzman, M.; Kunkel, M. W.; Salmon, S. E. cDNA microarray analysis of multidrug resistance: doxorubicin selection produces multiple defects in apoptosis signaling pathways. J. Pharmacol. Exp. Ther. 2001, 299, 434-441.
25. Chang, B. D.; Swift, M. E.; Shen, M.; Fang, J.; Broude, E. V.; Roninson, I. B. Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc. Natl. Acad. Sci. USA 2002, 99, 389-394.
26. Juliano, R. L.; Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim. Biophys. Acta 1976, 455, 152-162.
27. Childs, S.; Ling, V. The MDR superfamily of genes and its biological implications. Important Adv. Oncol. 1994, 21-36.
28. Cabot, M. C.; Giuliano, A. E.; Han, T. Y.; Liu, Y. Y. SDZ PSC 833, the cyclosporine A analogue and multidrug resistance modulator, activates ceramide synthesis and increases vinblastine sensitivity in drug-sensitive and drug-resistant cancer cells. Cancer Res. 1999, 59, 880-885.
29. Sietsma, H.; Veldman, R. J.; Kolk, D.; Ausema, B,; Nijhof, W.; Kamps, W.; Vellenga, E.; Kok, J. W. 1-phenyl-2-decanoylamino-3-morpholino-1-propanol chemosensitizes neuroblastoma cells for taxol and vincristine. Clin. Cancer Res. 2000, 6, 942-948.
30. Jaffrezou, J. P.; Levade, T.; Bettaieb, A.; Andrieu, N.; Bezombes, C.; Maestre, N.; Vermeersch, S.; Rousse, A.; Laurent, G. Daunorubicin-induced apoptosis: triggering of ceramide generation through sphingomyelin hydrolysis. EMBO J. 1996, 15, 2417-2424.
31. Beck, W. T.; Mueller, T. J.; Tanzer, L. R. Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts. Cancer Res. 1979, 39, 2070-2076.
32. Los, G.; Yang, F.; Samimi, G.; Manorek, G.; Guerorguieva, I.; Howell, S.; van Erp, N.; Breaux, J. Using mRNA Expression Profiling to Determine Anticancer Drug Efficacy. Cytometry 2002, 47, 66-71.
33. Zembutsu, H.; Ohnishi, Y.; Tsunoda, T.; Furukawa, Y.; Katagiri, T.; Ueyama, Y.; Tamaoki, N.; Nomura, T.; Kitahara, O.; Yanagawa, R.; Hirata, K.; Nakamura, Y. Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs. Cancer Res 2002, 62, 518-527.
34. 1. Molecular Cancer Therapeutics 2003, 2, 199-205.
35. Kumar, A.; Soprano, D. R.; Parekh, H. K. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel- resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma. Cancer Res. 2001, 61, 7552-7555.
36. Yoo, G.; Piechocki, M.; Ensley, J.; Nguyen, T.; Oliver, J.; Meng, H.; Kewson, D.; Shibuya, T.; Lonardo, F.; Tainsky, M. Docetaxel induced gene expression patterns in head and neck squamous cel carcinoma using cDNA microarray and PowerBlot. Clin Cancer Res 2002, 8, 3910-3921.
37. Wang, W.; Marsh, S.; Cassidy, J.; McLeod, H. L. Pharmacogenomic dissection of resistance to thymidylate synthase inhibitors. Cancer Res. 2001, 61, 5505-5510.
38. Huang, Q.; Dunn, R. T.; Jayadev, S.; DiSorbo, O.; Pack, F. D.; Farr, S. B.; Stoll, R. E.; Blanchard, K. T. Assessment of cisplatin-induced nephrotoxicity by microarray technology. Toxicol. Sci. 2001, 63, 196-207.
39. Staunton, J. E.; Slonim, D. K.; Coller, H. A.; Tamayo, P.; Angelo, M. J.; Park, J.; Scherf, U.; Lee, J. K.; Reinhold, W. O.; Weinstein, J. N.; Mesirov, J. P.; Lander, E. S.; Golub, T. R. Chemosensitivity prediction by transcriptional profiling. Proc. Natl. Acad. Sci. USA 2001, 98, 10787-10792.
40. Dan, S.; Tsunoda, T.; Kitahara, O.; Yanagawa, R.; Zembutsu, H.; Katagiri, T.; Yamazaki, K.; Nakamura, Y.; Yamori, T. An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines. Cancer Res, 2002, 62, 1139-1147.
41. Akutsu, N.; Lin, R.; Bastien, Y.; Bestawros, A.; Enepekides, D. J.; Black, M. J.; White, J. H. Regulation of gene Expression by 1alpha,25-dihydroxyvitamin D3 and Its analog EB1089 under growth-inhibitory conditions in squamous carcinoma Cells. Mol. Endocrinol. 2001, 15, 1127-1139.
42. Swami, S.; Raghavachari, N.; Muller, U.; Bao, Y.; Feldman, D. Vitamin D Growth inhibition of breast cancer cells: gene expression patterns assessed by cDNA microarray. Breast Cancer Res. Treat 2003, 80, 49-62.
43. Dong, Y.; Ganther, H. E.; Stewart, C.; Ip, C. Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays. Cancer Res. 2002, 62, 708-714.
44. Li, Z.; Khaletskiy, A.; Wang, J.; Wong, J.; Oberley, L.; Li, J. Genes regulated in human breast cancer cells overexpressing manganese-containing superoxide dismutase. Free Radic. Biol. Med. 2001, 30, 260-267.
45. Ishida, S., Shigemoto-Mogami, Y.; Kagechika, H.; Shudo, K.; Ozawa, S.; Sawada, J.; Ohno, Y.; Inoue, K. Clinically potential subclasses of retinoid synergists revealed by gene expression profiling. Mol. Cancer Ther. 2003, 2, 49-58.
46. Scudiero, D. A.; Monks, A.; Sausville, E. A. Cell line designation change: multidrug-resistant cell line in the NCI anticancer screen [letter]. J. Natl. Cancer Inst. 1998, 90, 862.
47. Sgroi, D. C.; Teng, S.; Robinson, G.; LeVangie, R.; Hudson, J. R., Jr.; Elkahloun, A. G. In vivo gene expression profile analysis of human breast cancer progression. Cancer Res. 1999, 59, 5656-5661.
48. Perou, C. M.; Sorlie, T.; Eisen, M. B.; van de, R. M.; Jeffrey, S. S., Rees, C. A.; Pollack, J. R.; Ross, D. T.; Johnsen, H.; Akslen, L. A.; Fluge, O.; Pergamenschikov, A.; Williams, C.; Zhu, S. X.; Lonning, P. E.; Borresen-Dale, A. L.; Brown, P. O.; Botstein, D. Molecular portraits of human breast tumours. Nature 2000, 406, 747-752.
49. Lonning, P. E.; Sorlie, T.; Perou, C. M.; Brown, P. O.; Botstein, D.; Borresen-Dale, A. L. Microarrays in primary breast cancer - lessons from chemotherapy studies. Endocr. Relat. Cancer 2001, 8, 259-263.
50. Hilsenbeck, S. G.; Friedrichs, W. E.; Schiff, R.; O'Connell, P.; Hansen, R. K.; Osborne, C. K.; Fuqua, S. A. Statistical analysis of array expression data as applied to the problem of tamoxifen resistance. J. Natl. Cancer Inst. 1999, 91, 453-459.